The rapid increases in cerebral vascular re sistance (CVR) frequently observed during extracorpo real perfusion of isolated organs with whole or diluted blood have been investigated using the isolated canine brain preparation. Our data strongly suggest that these increases are caused by a vasoconstrictor that is present in the buffy coal, Plasma serotonin levels were measured and found to be insignificant after conditioning and storage. Conditioning the blood reduced the platelets and Abbreviations used: CVR, cerebral vascular resistan ce; EDTA, ethylenediaminetetraacetate; NE, norepinephrine: RBC, red blood cell; TXA2, thromboxane A2; TXB2• thromboxane B2• 52 the potential for thromboxane Az production to -40% of normal. However, there was no correlation between thromboxane B, levels and increases in CVR. Removal of the buffy coat effectively removed all of the leuko cytes. Thus, one of the leukotrienes may have been re sponsible for the buffy coat-induced vasoconstriction.
Investigators studying the metabolism and phys iology of isolated organs as well as those involved with the long-term preservation of organs for trans plantation have observed persistent increases in the arterial pressure of those isolated organs subjected to extracorporeal perfusion (Humphries, 1967) . It has been suggested by most investigators that some component of the perfusate is responsible for these increases in pressure; however, that component has yet to be identified. Consequently, most measures taken to circumvent this problem emphasize elimi nating or decreasing the level of blood constituents believed to be responsible for vasoconstriction rather than blocking the synthesis or effect of a spe cific agonist. Geiger and Magnes (1947) reported that arterial pressure increased steadily when iso lated cat brains were perfused with bovine blood. Although they believed that recirculation through lung or liver tissue removed the vasoconstrictors, these investigators eventually resorted to using sim plified blood as a perfusate (30% bovine erythro-cytes suspended in a mixture of Ringer's solution and plasma albumin) (Geiger et aI., 1954) to amelio rate increases in vascular resistance. Swank and collaborators found that filtration of blood through glass or Dacron wool not only prevented the rapid increase in screen filtration pressure, thereby ex tending the viability of the perfused cat head, but also reduced the number of circulating platelets and leukocytes (Swank et at., 1963; Swank and Hissen, 1965) . The extended viability was in part attributed to the removal of factors that mechanically obstruct the vasculature. U sing a somewhat different ap proach, Belzer et al. (1968) utilized plasma from which the lipoproteins had been cryoprecipitated to maintain and preserve the isolated kidney for trans plantation. This procedure was believed to decrease the occurrence of fat emboli. Despite hemodilution and exhaustive filtration with nylon wool and poly ester screen filters, we continue to observe in creases in cerebral vascular resistance (CVR) during perfusion of the isolated brain.
In this study, we compare plasma levels of sero tonin and thromboxane B2 (TXB2) with the in creasing CVR in brains perfused with diluted dog blood containing and lacking platelets and leuko cytes. Plasma norepinephrine (NE) and epinephrine were measured to assess their impact on CVR im mediately after blood is conditioned. The levels of serotonin and TXB2 remained constant, whereas the catecholamines tended to decrease during the study. There was no significant correlation between increases in CVR and the level of any of the ago nists measured in this study. Because leukocytes are absent and the platelets in buffy coat-poor plasma appear to form little or no thromboxane A2 (TXA2), it would appear that the principal vasocon strictor may arise from the leukocyte.
METHODS

Brain isolation
We isolated the brains from 18 adult mongrel dogs weighing 10-18 kg. The animals received 2.0 mg of suc cinylcholine to facilitate intubation. Anesthesia was in duced and maintained with halothane.
The procedure for brain isolation involved removal of the mandible, the zygomatic arch, the snout, and all ex tracranial soft tissue, leaving only the brain case intact. A laminectomy at the level of the second cervical ver tebra permitted ligation and transection of the spinal cord, dura, and vertebral sinuses. Blood was supplied to the brain through the internal carotid arteries and the anastomotic branch of the internal maxillary segment of the external carotid arteries. A hole was drilled into the confluence of the venous sinuses and a Luer connector installed, thereby allowing return of the venous blood to the reservoir. A more complete description of the method for canine brain isolation was presented in an earlier com munication (Gilboe et aI., 1973) .
Following isolation, the halothane diffused from the brain tissue to the anesthetic-free blood of the perfusion system and subsequently evaporated from the oxygen ator. Within 45 min after isolation the preparation became relatively free of the influence of anesthetic (Fitzpatrick and Gilboe, 1982) .
Treatment of blood
The donor dog blood was anticoagulated with heparin (500 u/kg) and infused with sufficient 6% dextran 75 (500-1,000 m!) to achieve a final hematocrit of 30%. Fol lowing 2 h of recirculation and filtration, the donor was exsanguinated, 15,000 U/L of heparin was added to the blood, and half of the blood was stored at 4°C with no further treatment. The other half was processed as fol lows. The blood was centrifuged at 365 g for 30 min at 4°C in an RC-3 centrifuge (Sorvall) equipped with a GS-3 rotor. The buffy coat-rich plasma was separated from the red blood cells (RBCs) and set aside. The RBCs were washed three times with 100 mg% glucose in 0.9% saline, filtered through 10 g of nylon wool, and stored at 4°C. The buffy coat-rich plasma was centrifuged at 4,920 g for 15 min at 4°C. The buffy coat-poor plasma was then de canted and filtered, first through a 40-fLm polyester screen filter (Pall Corporation, Glen Cove, NY, U.S.A.) and then sequentially through 5-, 0.45-, and 0.2-fLm Me tricel membrane filters (Gelman Sciences, Ann Arbor, MI, U.S.A.) to ensure removal of most of the remaining platelets and leukocytes. The buffy coat-poor plasma and RBCs were recombined to a hematocrit of 30% and used as control blood. All handling of plasma was done in plastic ware or siliconized glass.
Perfusion system
Prior to isolation, 800-1,000 ml of treated blood was used to prime one of the two interconnected perfusion systems. The second system received an equal volume of untreated blood. Arterial blood was propelled by a vari able-speed roller pump from the Silastic reservoir through the various components of the perfusion system, in cluding a manifold for the connection of a pressure trans ducer (Statham P23ID) (Kintner et aI., 1980) , into T-con nectors placed in the common carotid arteries near the bifurcation of the internal and external carotid arteries. At the time of isolation, the pump was adjusted to deliver � 70 ml biood/ IOO g brain/min.
Perfusion conditions
Blood pH, Po2, Pco2, and total oxygen were measured as described in an earlier report (Kintner et aI., 1984) . Arterial plasma glucose was assayed in triplicate (Beckman glucose analyzer; Beckman Instruments, Ful lerton, CA, U.S.A.) and maintained at �5.5 mM by ad dition of a 5% glucose solution. Arterial temperature was monitored and held constant at 37°C throughout the study. The cerebral blood flow rate was determined by measuring the volume of all venous blood flowing from the confluence of sinuses for 1 min.
These studies were performed using two separate but interconnected perfusion systems (Kintner et aI., 1980) . Tr eated blood was used to maintain the brain until the experiment started. Blood pH and Paco2 were maintained at �7.40 and 40 mm Hg, respectively, in both the control and the experimental systems by regulating the gas mix ture and adding bicarbonate.
Arterial perfusion pressure and the EEG were contin uously monitored during the course of the experiment and recorded using a Grass model 78 polygraph. Measure ment of plasma osmolality was made by freezing point depression (fLOsmette; Precision Instruments, Sudbury, MA, U.S.A.). Nitroglycerin infusions were done with a Harvard syringe pump attached to a needle placed in a rubber injection port immediately distal to the point of blood entry into the carotid arteries. At the termination of each experiment, the brain was removed from the skull and weighed.
Sample collection and analysis
Blood for serotonin and catecholamine determination, from the buffy coat-rich and -poor groups when appro priate, was collected at I-h intervals during the 2-h con ditioning procedure, following overnight storage at 4°C, immediately prior to brain perfusion and following 1 h of brain perfusion. Plasma serotonin (Koch and Kissinger, 1979) and catecholamines (Bioanalytical Systems, 1982) were separated by reverse-phase HPLC (C 18 fL-Bonda pack column; Alltech Associates, Deerfield, IL, U.S.A.). The peaks were integrated and samples quantified ac cording to a previously established standard curve. Un bound serotonin and internal standard (methyl-5-hy droxytryptamine) were measured in the supernatant re sulting from perchloric acid precipitation of plasma. Fifty microliters of sample was injected onto a column with a mobile phase that was 90% an aqueous solution of 4.8 mM ethylenediaminetetraacetate (EDTA) in 0.5 M am monium acetate, pH 5.1, and 10% methanol (vollvol) that flowed at 1 mllmin. To tal plasma serotonin (bound and unbound) was determined in a similar manner following the addition of 20 U of thrombin to I ml of plasma (Willis et a!., 1974) . Plasma catecholamines plus internal stan dard (3,4-dihydroxybenzylamine) were absorbed on acid washed alumina, and the alumina was washed with dis tilled water, spun to dryness, and eluted with perchloric acid. Fifty microliters of the eluate was injected onto a column with a mobile phase that was 92% of 0.1 M KH2P04, 1.37 mM EDTA, and 0.92 mM sodium I-octane sulfonic acid, and 8% methanol (vol/vol). This mixture was pumped through the column at the rate of 1 mllmin.
Effectiveness of platelet and leukocyte removal
The correlation of platelet and leukocyte numbers with the tendency of CVR to increase during perfusion was evaluated in two separate studies.
In the first study, blood was drawn into plastic heparin coated syringes (final concentration 25 U/ml) or con taining 1 part of 3.8% trisodium citrate in 9 parts of blood (vol/vol). The tubes were centrifuged at 250 g for 6-10 min and the buffy coat-rich plasmas separated. Platelet counts were performed on 1 fLl of 1 :200 diluted buffy coat rich plasmas using the Rees-Ecker light microscopy method (Platt, 1969) . Leukocytes were counted in a sim ilar manner using a Unopette collection system (Becton Dickenson, Rutherford, NJ, U.S.A.) with a final dilution of 1: 100. A I-ml aliquot from each buffy coat -rich plasma sample was then challenged with 20 U of thrombin (Willis et a!., 1974) and incubated for 1 h at 37°C. The samples were frozen and stored at -70°C prior to assay for TXB2• The remainder of each buffy coat-rich plasma sample was centrifuged at 2,500 g for 15 min to separate the buffy coat-poor plasma. The platelets were counted, and the plasmas were challenged with thrombin and stored at -70°C prior to assay for TXB2.
In the second study, blood samples were collected in arterial-venous pairs at 15-min intervals for up to I h during brain perfusion with untreated blood. Samples were drawn into plastic tubes coated with 4.5 mM EDTA and 10 fLg/ml aspirin and mixed to inhibit additional TXA, production. The tubes were centrifuged at 2,500 g, and the buffy coat-poor plasma was separated and stored at -70°C prior to assay for TXB2• The change to plasma TXB2 levels was correlated with changes in CVR during brain perfusion.
The Seragen (Boston, MA, U.S.A.) TXB2 3H-radioim munoassay kit was used to measure TXB2 levels in plasma. A sample of plasma was added to eHjTXB2 and allowed to compete for a limited number of sites on a specific antibody. The excess TXB2 was removed using dextran-coated charcoal and the remaining antibody bound eHjTXB2 counted on a Beckman LS 3801 (Irvine, CA, U.S.A.) liquid scintillation system. Plasma samples were compared with an appropriately constructed stan dard curve.
Perfusion of two brains in sequence with the same perfusate
We questioned whether the accumulation of a vaso constrictor or some other phenomenon was responsible for the increase in CVR observed during perfusion with buffy coat-poor blood. We reasoned that a vasocon strictor, if present, would cause a rapid increase in the CVR of a second preparation. To study this we perfused the three isolated brains for �2-3 h and monitored the various metabolic variables and arterial perfusion pres sure. We then repeated the procedure with a second iso lated brain perfused with the same blood. 
RESULTS
Effect of buffy coat on CVR
In eight preparations used for metabolic studies under control conditions, the brain was perfused with blood in which the buffy coat (primarily plate lets and leukocytes) was removed. There was a 24% increase in CVR during the first hour of perfusion ( Fig. I, lower line) . When these data are compared with data from earlier studies done under similar conditions using blood that contained the usual amount of platelets and leukocytes (Fig. I, upper line), we observed a dramatically different pattern. Not only was the initial CVR 122% higher than that in the control group, but the increase in CVR was 48% of the initial value for the buffy coat-rich group after the first hour of perfusion.
In four preparations, perfusion was initiated with buffy coat-poor plasma, then switched to buffy coat rich plasma for 45 min, and finally returned to buffy coat-poor plasma for 20 min (Fig. 2 ). There was little or no increase in CVR when the buffy coat poor perfusate was used. When perfusion with buffy coat-rich plasma was started, the CVR in creased at a rate similar to that seen with buffy coat rich plasma alone (Fig. 1) . However, we did not observe an immediate increase in CVR corre sponding to the difference in initial CVRs (Fig. 1) . During reperfusion with buffy coat-poor plasma, the CVR decreased to near initial levels. 
Evidence for vasoconstrictor activity
The platelet has long been suspected of playing a role in the reduction of blood flow during extra corporeal perfusion via mechanical obstruction of the vasculature. Isolated brain preparations were fixed in situ following 1-2 h of perfusion with either buffy coat-rich or -poor blood. Following both treat ments, the cortex was examined by electron mi croscopy and the capillaries were of normal caliber and free of debris (Dr. Larry Jenkins, personal com munication). This is not surprising in view of the exhaustive filtration to which the donor blood was subjected.
In three buffy coat-rich -perfused preparations used for metabolic studies under control conditions, the brain was infused with nitroglycerin, a nonspe cific smooth muscle relaxation, at blood concentra tions ranging from to-10 to to -2 M. All infusions were made on brains exhibiting increased CVRs fol lowing perfusion with buffy coat-rich blood for at least 2 h. Nitroglycerin was shown to cause a dose dependent decrease in CVR. However, when infu sion was stopped, the effect was counteracted within minutes. The dose that caused maximum va sodilation also caused the EEG to display a seizure pattern. Although the CVR decreased as much as 40% with nitroglycerin infusion, it never ap proached the initial perfusion values. These data suggest that the increased CVR was caused by a vasoconstrictor.
In three instances, buffy coat-poor blood was uti lized to perfuse a second isolated brain. In all cases, the second brain had an initial CVR similar to the final CVR observed with the first preparations. The CVR continued to rise at approximately the same rate as it did with the first isolated brain prepara tions. This suggests that a vasoconstrictor is re- leased into the buffy coat-poor plasma from either a remaining component of the buffy coat or another source.
In a study of plasma from eight randomly selected donor dogs, the plasma osmolarity was found to be 300 ± 4 mOsmol. At the time of brain perfusion, the osmolarity in the buffy coat-poor and -rich plasma was 3tO ± 3 and 310 ± 4 mOsmol, respec tively. This slight increase in osmolarity was due to the sodium bicarbonate added to correct the nega tive base excess caused by lactate accumulation during overnight storage of blood. There was no relationship between osmolarity and CVR during the early part of the experimental period, and no further change in the plasma osmolarity was ob served during the remainder of the perfusion pe riod. The slightly higher osmolarity of plasma used to perfuse the brain would tend to shrink, not swell, capillary endothelial cells. Thus, plasma osmolarity should have played no role in the increase in CVR observed in these studies.
The mean (± SEM) blood pH, Paco2, and Pao2 values during perfusion with either buffy coat-poor or -rich blood in the same experiment are shown in Ta ble 1. The data include four samples from each group (poor and rich) collected from each of four preparations. Approximately 8-12 ml of I N so dium bicarbonate was added per liter of blood to restore the pH to normal before the start of perfu sion. The blood gases and pH were similar in all studies. Thus, it is doubtful that they play a role in the CVR changes observed during these studies.
Buffy coat vasoconstrictor
In to experiments, the efficiency of platelet re moval in reducing the plasma thromboxane levels was studied. Platelet counts were performed and production of TXA2 was measured by assaying for TXB2 after thrombin challenge in citrated buffy coat-rich plasma, citrated buffy coat-poor plasma, heparinized buffy coat-rich plasma, and heparinized buffy coat-poor plasma ( Table 2) . We selected ci trate as an anticoagulant because it appeared to be the most suitable for the study of platelet metabo lism, in particular, the TXA2 release reaction. We observed frequent platelet clumping in both ci trate-and heparin-treated plasmas. For the sake of comparing platelet counts and TXB2 production, we decided that only free unclumped platelets would be enumerated in platelet counts. Consequently, our average platelet counts are somewhat lower than normal. Ta ble 2 shows that centrifugation and filtration reduce the unclumped platelet counts by 72% in citrated plasma and 57% in heparinized plasma. Although TXB2 production was reduced by 65% in citrated plasma and by 33% in heparinized plasma, the difference in TXB2 production between citrated and heparinized buffy coat-poor plasma was not statistically significant. In general, TXB2 production appeared to be closely related to the number of platelets that were present. The data sup port our belief that treatment of the blood removes a significant proportion of the platelets and the cor responding potential for TXA2 production. Ta ble 3 lists plasma levels of TXB2 during the course of brain perfusions with buffy coat-rich blood. Each of the preparations exhibited increases in CYR during the course of the experiment. How ever, the plasma TXB2 levels do not increase and in fact are comparable with those seen after thrombin challenge (Table 2 ). This suggests that there is little potential for additional TXA2 produc tion during the perfusion period. Thus, it appears unlikely that increases in CYR during brain perfu sion are the result of constriction of the cerebral vasculature by TXA2• Because TXA2 is so rapidly converted to TXB2, the initial level of TXB2 will be unrelated to the initial CYR in the buffy coat-rich group. The removal of platelets appears to play a significant role in reducing the potential for plasma TXA2 production, and there appears to be little TXA2 production during brain perfusion.
In six experiments, leukocytes were counted in citrated buffy coat-rich plasma (14.3 x 10 3 ± 0.5 cel\s/(-Ll), citrated buffy coat-poor plasma (0 cells/ (-Ll), heparinized buffy coat-rich plasma (12.9 x 10 3 ± 0.5 cells/(-Ll) , and heparinized buffy coat-poor plasma (0 cells/(-Ll). Clumping was not observed. These data indicate that centrifugation removes all the leukocytes in both heparinized and citrated plasma. Thus, after processing, the blood used in our preparation can be considered leukocyte-free.
Other vasoactive substances
Other vasoconstrictors were measured to deter mine whether the slow increase in CYR during buffy coat-poor perfusion might be attributed to their action. Ta ble 4 shows the plasma concentra tions of serotonin, NE, and epinephrine in the per fusate during the conditioning of the blood and be fore and during extracorporeal perfusion. There is an initial release of serotonin from platelets as the blood passes through the nylon filter, but no signif icant release occurs after 1 h of conditioning. Most of the serotonin appears to remain bound to the platelet and unavailable to act on the vascular smooth muscle. During perfusion of the brain, the plasma concentration is <4.14 x 10-10 M, an amount far below the concentration known to cause vasoconstriction in our preparation (5.89 x 10-9 M) (D. Gilboe, unpublished data) . Thus, it is un likely that serotonin is the factor causing the in crease in CYR during extracorporeal perfusion of the brain.
Although catecholamines do not orignate in the buffy coat, they were believed at one time to play a role in cerebral vasoconstriction, particularly when freshly drawn blood was used to prime the perfusion system. The plasma catecholamine levels increase dramatically during the conditioning pro cedure, decrease during overnight storage at 4°C, and remain nearly unchanged during extracorporeal perfusion. The minimum amount of catecholamine necessary to elicit a detectable vasoconstriction is 10 2 _10 4 of the concentration measured in the donor plasma (Saffitz et aI., 1979) . Thus, it would appear that plasma catecholamine levels are below the range that will cause vasoconstriction and thus play no role in the increase in CYR observed during ex tracorporeal brain perfusion.
DISCUSSION
Although there is the suggestion by many authors that mechanical obstruction by lipids, denatured li poprotein, platelets, platelet aggregates, and leu- kocytes may be responsible, we believe that the in creased CVR in our preparation is the result of va soconstrictor activity. The literature is repleat with vague descriptions of vasoconstrictors that seem to be present in blood under various conditions (Siesjo and Nilsson, 1982; White and Hagen, 1982; Wo odman and Dusting, 1983) . However, most of the procedures utilized to decrease blood pressure in perfused organs simultaneously decrease blood platelet or leukocyte levels (Geiger and Magnes, 1947; Geiger et aI., 1954; Swank and Hissen, 1965; Belzer et aI., 1967) . Removal of these tissues could influence the plasma levels of a variety of vasocon strictors including both serotonin and thrombox anes from platelets and leukotrienes from leuko cytes. It is clear from this study that CVR was initially lower and the rate of increase in CVR during extra corporeal perfusion was reduced when the buffy coat was removed. When the buffy coat was present, the initial CVR was 122% higher than with buffy coat-poor blood. Furthermore, the CVR in creases at twice the rate observed with buffy coat poor blood during the first hour of perfusion. These two phenomena may well be caused by different mechanisms. Because the increases in CVR can be controlled by nitroglycerin infusion and there is no evidence of mechanical blockage of the vascula ture, it is suggested that a vasoconstrictor is re sponsible.
Although serotonin and TXA2 are normally re leased by the platelets, there is no evidence that a significant increase in either serotonin or TXA2 oc curs during perfusion with buffy coat-rich or -poor plasma. Serotonin was present in plasma, but the level after 2 h of conditioning was much lower, sug gesting that considerable breakdown had occurred during the process. At no time was the level of se-rotonin high enough to cause vasoconstnctlOn in the isolated dog brain. Although plasma TXB2 levels were elevated in buffy coat-rich plasma, in dicating release of the short-lived TXA2 had oc curred during overnight storage, there was no evi dence that significant quantities of TXA2 were re leased during perfusion with buffy coat-rich blood. Thus, it is doubtful that TXA2 is responsible for the increase in CVR. Neither of the vasoconstrictors present in the platelet is released in quantities suf ficient to cause vasoconstriction during extracor poreal perfusion.
If a vasoconstrictor is responsible for the steady increase in CVR during perfusion with buffy coat rich blood, it probably is released by the leukocyte. All leukocytes are removed when the buffy coat is removed; thus, the vasoconstriction observed with buffy coat-rich plasma seems to coincide with the presence of the white cell. There are several can didates for the vasoconstrictor, among them is leu kotriene C 4 . There are no readily available assays for this substance at this time, and confirmation of this hypothesis must wait.
Removing the buffy coat from blood does reduce the extent of increases in CVR during perfusion; however, it is unlikely that either the platelets or the leukocyte-released vasoconstrictors play a role in the CVR increase observed with buffy coat-poor blood. This study suggests that neither serotonin nor TXA2 is an important vasoconstrictor during extracorporeal perfusion of the brain. Because leu kocytes are completely removed, vasoconstriction during buffy coat-poor perfusion is not due to re lease of a leukotriene. Even if catecholamine levels were maintained during blood storage, they would be incapable of causing vasoconstriction because their concentration is too low. Thus, vasoconstric tion during buffy coat-poor perfusion may be due to some as yet to be identified factor(s). For ex ample, immunoglobulin G may bind to the polymer surface of the nylon filters and activate the comple ment system (U ehida et aI., 1984) . Immunoglobulin G absorption is highly variable depending on the exposure of specific functional groups during man ufacture. If the complement cascade is activated, then various components (i.e., C3 and C5) having vasoconstrictive properties may be formed (Crad dock et aI., 1977) . Alternatively, extracorporeal perfusion of the brain may result in changes in serum calcium balance and membrane permeability that in turn may cause an increase in tonic contrac tions of arteriolar smooth muscles (Bohr and Webb, 1984) .
